Congratulations to Dr. Daechan Park who has accepted a position at KIST (Korea Institute of Science and Technology)!
Congratulations to alum Dr. Ki Jun Jeong on his promotion to Associate Professor with Tenure at KAIST! http://proteineng.cafe24.com/xe/
Congratulations to Ahlam Qerqez who has been accepted to the graduate program at UT Austin in the Chemical Engineering Department. Ahlam will join alum Jennifer Maynard’s lab. https://sites.google.com/site/maynardlabatut/Home
Congratulations to Giulia Agnello for successfully defending her thesis, “Development of Human Enzymes for Amino Acid Depletion Therapy,” April 2016. Giulia has accepted a Research Scientist position at Aeglea Biotherapeutics, Inc.
Congratulations to alum Dr. Navin Varadarajan on being promoted to Associate Professor at University of Houston! http://singlecell.chee.uh.edu/
Researchers at The University of Texas at Austin, including Texas ChE’s Dr. George Georgiou and Dr. Jennifer Maynard, successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA). Part of the molecule was engineered at UT Austin before being licensed to New Jersey-based pharmaceutical company Elusys Therapeutics for further development. It will be sold under the name Anthim.
- The Institute Joins Universal Influenza Vaccine Consort...February 14, 2020 - 2:36 PM
- Dr. Everett Stone Competes on Forged in Fire on the History...September 26, 2019 - 4:13 PM
- New cancer treatment uses enzymes to boost immune system...August 29, 2018 - 2:18 PM
- GRA George Delidakis wins Poster Prize at EMBO Antibodies...August 21, 2018 - 6:56 PM